Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Pubmed

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Download PDF

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Näntö-Salonen, Kirsti; Kupila, Antti; Simell, Satu; Siljander, Heli; Salonsaari, Tiina; Hekkala, Anne; Korhonen, Sari; Erkkola, Risto; Sipilä, Jukka I; Haavisto, Lotta; Siltala, Marja; Tuominen, Juhani; Hakalax, Jari; Hyöty, Heikki; Ilonen, Jorma; Veijola, Riitta; Simell, Tuula; Knip, Mikael; Simell, Olli
The Lancet , Volume 372 (9651): -1690 – Dec 1, 2008

Loading next page...
 
/lp/pubmed/nasal-insulin-to-prevent-type-1-diabetes-in-children-with-hla-GsVRf3QOA5

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0140-6736
DOI
10.1016/S0140-6736(08)61309-4
pmid
18814906

Abstract

Journal

The Lancet – Pubmed

Published: Dec 1, 2008

There are no references for this article.